Allegheny Health Network Names Jonathan Lee, MD, System-wide Director of Surgical Oncology and Director of Surgery, AHN Cancer Institute
Friday, November 16, 2018
PITTSBURGH, Pa. -- Dr. Jonathan Lee, a nationally recognized surgical oncologist, has been named the Director of Surgery and System-wide Director of Surgical Oncology serving in a dual role for Allegheny Health Network (AHN) Cancer Institute and the AHN Surgery Institute, respectively.
In his new role, Dr. Lee will oversee AHN’s surgical oncology program, as well as AHN Cancer Institute’s 13 Disease Sites, with a primary focus on the standardization and effective coordination of high-quality, compassionate surgical care in all related disciplines for patients before, during and after their cancer treatment. He’ll also work to help further establish and better integrate multidisciplinary cancer care teams across the network while also increasing AHN’s participation in innovative clinical trials and academic research.
“Dr. Lee is an extremely talented surgeon and physician leader who has demonstrated a unique ability to envision, create and formalize programs which optimize a patient’s navigation of the care journey and ensure they have access to the best possible care options and support services,” said Ngoc Thai, MD, Ph.D. Chair of Surgery Institute for AHN. “We look forward to the continued success of our surgical oncology program under his direction.”
Prior to joining AHN, Dr. Lee served as Medical Director for the Melanoma and Sarcoma Program at the Northside Hospital Cancer Institute (NHCI) based in Atlanta, Georgia. In that role, he developed and led multidisciplinary clinical cancer programs centered on community outreach and disease prevention, care optimization, and advancing standards through clinical cancer research.
Dr. Lee brings an advanced skillset to AHN with a heightened focus on patient care, coordination and clinical research. An integral member of NHCI, he also served as Chairman of Research Advisory Committee, Chairman of the Melanoma and Sarcoma Steering Committee as well as Medical Director of the Melanoma Research Program.
“At AHN, we embrace a highly collaborative, multi-disciplinary and personalized approach to the care of cancer patients, bringing together diverse clinical expertise and support services to assure that our patients have every resource they need to fight and win their battle with this disease,” said David Parda, MD, Chair of the Cancer Institute. “In addition to bringing additional capabilities in the treatment of melanoma and sarcoma to our system and to the region, Dr. Lee shares our core values and vision for how best to care for those who are faced with a cancer diagnosis. He will be an invaluable asset to our Cancer Institute team as we continue to transform, innovate and grow as a local and nationally-leading cancer care provider.”
As part of his practice, Dr. Lee is committed to seeking out and providing opportunities for advanced learning and innovative thinking, across all disciplines. For seven years, he served as an Assistant Professor of Surgery, Division of Surgical Oncology at Robert Wood Johnson Medical School.
Certified by the American Board of Surgery, Dr. Lee is active member of several local and national professional organizations including the Society of Surgical Oncology, the American Society of Clinical Oncology and the Melanoma Research Society. He was the founding physician of the Melanoma and Sarcoma Specialists in Georgia and has been recognized by Atlanta Magazine as a “Castle Connolly” Top Doctor for four consecutive years.
A graduate of Amherst College, Dr. Lee earned his medical degree at New York University. His post-graduate training included residency at the University of Rochester and Surgical Oncology Fellowship at John Wayne Cancer Institute in Santa Monica, California.